Non-tuberculosis Mycobacterium Pulmonary Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-02-28
Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease [Phase 2]
Phase 2 study of SPR720 for Mycobacterium avium complex pulmonary disease was terminated; results were posted.